0001162044-20-001430.txt : 20201124
0001162044-20-001430.hdr.sgml : 20201124
20201124142238
ACCESSION NUMBER: 0001162044-20-001430
CONFORMED SUBMISSION TYPE: NT NPORT-P
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200831
FILED AS OF DATE: 20201124
PERIOD START: 20210331
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSA SERIES TRUST
CENTRAL INDEX KEY: 0001027657
IRS NUMBER: 161517067
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: NT NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-07963
FILM NUMBER: 201342730
BUSINESS ADDRESS:
STREET 1: 507 PLUM STREET SUITE 120
STREET 2: .
CITY: SYRACUSE
STATE: NY
ZIP: 13204
BUSINESS PHONE: (315) 251-1101
MAIL ADDRESS:
STREET 1: 507 PLUM STREET SUITE 120
STREET 2: .
CITY: SYRACUSE
STATE: NY
ZIP: 13204
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STATE OPPORTUNITY FUNDS
DATE OF NAME CHANGE: 19961126
0001027657
S000004908
NYSA Fund
C000013264
NYSA Fund
NYSAX
NPORT-P
1
primary_doc.xml
NPORT-P
false
0001027657
XXXXXXXX
S000004908
C000013264
NYSA SERIES TRUST
811-07963
0001027657
549300HGVY2IMD2RFV95
507 Plum Street
Suite 120
Syracuse
13204
315-251-1101
NYSA Fund
S000004908
549300W8D7D8IYFXGT87
2021-03-31
2020-08-31
Y
1704636.82
34354.84
1670281.98
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
500.00
N
N/A
N/A
Central New York Raceway Park Inc.
N/A
25000.00
NS
USD
0.00
0.00
Long
EC
CORP
US
N
1
N
N
N
Federated Hermes Money Market Obligations Trust
25490005VWJDWX717014
Federated Treasury Obligation Fund - Insitutional Shares
60934N500
1223143.60
NS
USD
1223143.60
73.23
Long
STIV
RF
US
N
1
N
N
N
Ligand Pharmaceuticals, Inc.
5493008K7TB0IKP37H79
Ligand Pharmaceuticals Inc. Class B
53220K504
500.00
NS
USD
51000.00
3.05
Long
EC
CORP
US
N
1
N
N
N
N/A
N/A
Transluminal Technologies LLC
N/A
84332.00
NS
USD
400577.00
23.98
Long
EC
CORP
US
N
2
N
N
N
2020-08-31
NYSA Series Trust
/s/ Robert Cuculich
Robert Cuculich
President